BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

333 related articles for article (PubMed ID: 10353862)

  • 1. Thalidomide for the treatment of esophageal aphthous ulcers in patients with human immunodeficiency virus infection. National Institute of Allergy and Infectious Disease AIDS Clinical Trials Group.
    Jacobson JM; Spritzler J; Fox L; Fahey JL; Jackson JB; Chernoff M; Wohl DA; Wu AW; Hooton TM; Sha BE; Shikuma CM; MacPhail LA; Simpson DM; Trapnell CB; Basgoz N
    J Infect Dis; 1999 Jul; 180(1):61-7. PubMed ID: 10353862
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thalidomide for the treatment of oral aphthous ulcers in patients with human immunodeficiency virus infection. National Institute of Allergy and Infectious Diseases AIDS Clinical Trials Group.
    Jacobson JM; Greenspan JS; Spritzler J; Ketter N; Fahey JL; Jackson JB; Fox L; Chernoff M; Wu AW; MacPhail LA; Vasquez GJ; Wohl DA
    N Engl J Med; 1997 May; 336(21):1487-93. PubMed ID: 9154767
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thalidomide in low intermittent doses does not prevent recurrence of human immunodeficiency virus-associated aphthous ulcers.
    Jacobson JM; Greenspan JS; Spritzler J; Fox L; Fahey JL; Jackson JB; Chernoff M; Wohl DA; Pulvirenti JJ; Hooton TM; Shikuma C
    J Infect Dis; 2001 Jan; 183(2):343-346. PubMed ID: 11120935
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thalidomide as therapy for human immunodeficiency virus-related oral ulcers: a double-blind placebo-controlled clinical trial.
    Ramirez-Amador VA; Esquivel-Pedraza L; Ponce-de-Leon S; Reyes-Teran G; Gonzalez-Guevara M; Ponce-de-Leon S; Sierra-Madero JG
    Clin Infect Dis; 1999 Apr; 28(4):892-4. PubMed ID: 10825055
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thalidomide effective for oral ulcers.
    Posit Aware; 1996; 7(1):5. PubMed ID: 11363120
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thalidomide Celgene Corp.
    Bruyn GA
    IDrugs; 1998 Aug; 1(4):490-500. PubMed ID: 18465584
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Crossover study of thalidomide vs placebo in severe recurrent aphthous stomatitis.
    Revuz J; Guillaume JC; Janier M; Hans P; Marchand C; Souteyrand P; Bonnetblanc JM; Claudy A; Dallac S; Klene C
    Arch Dermatol; 1990 Jul; 126(7):923-7. PubMed ID: 2193629
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Efficacy of thalidomide in the treatment of esophageal ulcers in human immunodeficiency virus infection].
    Sire S; Fraisse P; Rey D; Jacquemin C; Kempf G; Partisani M; Lang JM
    Gastroenterol Clin Biol; 1995 Jan; 19(1):128-9. PubMed ID: 7720975
    [No Abstract]   [Full Text] [Related]  

  • 9. Thalidomide effective treatment for AIDS-related mouth ulcers.
    Randall P
    NIAID AIDS Agenda; 1995 Dec; ():2. PubMed ID: 11363350
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety, tolerability, and pharmacokinetic effects of thalidomide in patients infected with human immunodeficiency virus: AIDS Clinical Trials Group 267.
    Wohl DA; Aweeka FT; Schmitz J; Pomerantz R; Cherng DW; Spritzler J; Fox L; Simpson D; Bell D; Holohan MK; Thomas S; Robinson W; Kaplan G; Teppler H;
    J Infect Dis; 2002 May; 185(9):1359-63. PubMed ID: 12001058
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Idiopathic esophageal ulceration associated with human immunodeficiency virus infection: efficacy of thalidomide treatment.
    Louvel D; Musso S; Métivier S; Croizet O; Rouquet RM; Massip P; Escourrou J; Frexinos J
    Endoscopy; 1996 Jun; 28(5):471-2. PubMed ID: 8858251
    [No Abstract]   [Full Text] [Related]  

  • 12. Thalidomide effective for AIDS-related oral ulcers.
    Thompson C
    Lancet; 1995 Nov; 346(8985):1289. PubMed ID: 7475726
    [No Abstract]   [Full Text] [Related]  

  • 13. Thalidomide and HIV: several possible uses.
    Smith D
    AIDS Treat News; 1995 Apr; (no 221):1-4. PubMed ID: 11362402
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thalidomide for mouth ulcers and wasting.
    Baker R
    BETA; 1995 Dec; ():8. PubMed ID: 11363016
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Idiopathic esophageal ulceration in acquired immunodeficiency syndrome: successful treatment with misoprostol and viscous lidocaine.
    Adeoti AG; Vega KJ; Dajani EZ; Trotman BW; Kloser PC
    Am J Gastroenterol; 1998 Nov; 93(11):2069-74. PubMed ID: 9820375
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thalidomide for severe aphthous ulceration in patients with human immunodeficiency virus (HIV) infection.
    Oldfield EC
    Am J Gastroenterol; 1994 Dec; 89(12):2276-7. PubMed ID: 7977265
    [No Abstract]   [Full Text] [Related]  

  • 17. Thalidomide study.
    Proj Inf Perspect; 1997 Jul; (22):14-5. PubMed ID: 11364572
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Single-dose fluconazole versus standard 2-week therapy for oropharyngeal candidiasis in HIV-infected patients: a randomized, double-blind, double-dummy trial.
    Hamza OJ; Matee MI; Brüggemann RJ; Moshi MJ; Simon EN; Mugusi F; Mikx FH; van der Lee HA; Verweij PE; van der Ven AJ
    Clin Infect Dis; 2008 Nov; 47(10):1270-6. PubMed ID: 18840077
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thalidomide: an alternative therapy for treatment of apthous ulcers (canker sores).
    Manesis DA
    STEP Perspect; 1995; 7(1):16-7. PubMed ID: 11362397
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Idiopathic esophageal ulceration in patients infected with human immunodeficiency virus.
    Vega KJ; Bollu J; Dajani EZ; Trotman BW
    J Assoc Acad Minor Phys; 1996; 7(4):93-8. PubMed ID: 8936935
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.